New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
08:09 EDTCOV, NYXCovidien continues relationship with NYSE Euronext
Covidien (COV) announced that Mallinckrodt intends to apply to list its ordinary shares on the New York Stock Exchange, or NYSE, to trade under the symbol MNK. As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013. "We are very pleased to continue our relationship with the NYSE and look forward to enhancing our brand image in conjunction with NYSE Euronext (NYX)," said Josť E. Almeida, Chairman, President and CEO. "After a careful review, we decided that Mallinckrodt should be listed on the NYSE. We recognize the value of their deep community, unique visibility opportunities and innovative market structure, and believe it is in the best interest of both companies to be aligned with the NYSE. We look forward to continuing our strong and long engagement with the world's leading global exchange."
News For COV;NYX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
October 8, 2014
10:46 EDTCOVOptions with decreasing implied volatility
Subscribe for More Information
October 7, 2014
10:43 EDTCOVOptions with decreasing implied volatility
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use